October 25, 2023
This new partnership will provide integrated end-to-end solutions from sample to report for whole genome nanopore sequencing in future clinical applications. OXFORD, United Kingdom -- Oxford Nanopore Technologies plc (Oxford Nanopore), the company delivering a new generation of nanopore-based molecular sensing technology, and Saphetor, the next generation sequencing data analysis company, today announce a new [...]
October 24, 2023
THOUSAND OAKS, Calif. - The Board of Directors of Teledyne Technologies Incorporated (NYSE:TDY) announced today that Robert Mehrabian will be named Executive Chairman, effective January 1, 2024. As Executive Chairman, Dr. Mehrabian will remain actively involved with the company with a particular focus on strategy, technology, mergers and acquisitions and margin expansion programs. Dr. Mehrabian's [...]
Irish SME Announces World’s First Commercial Deployment of Novel Table-Top Soft X-ray Microscope
October 24, 2023
- SiriusXT’s SXT-100 has been commissioned at University College Dublin - Over twenty European and US-based organisations evaluating the SXT-100 Pictured (l-r) are; Dr Dimitri Scholz, Director of Biological Imaging, UCD Conway Institute; Professor Jeremy Simpson, Dean of Science and Principal, UCD College of Science and Dr Kenneth Fahy, co-founder & Vice-President for Product Management, [...]
October 24, 2023
First out-of-the-box, low-code SaaS platform designed together by scientists and technologists to shorten drug discovery funnel, reduce costs of drug therapy R&D Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced the launch of Dotmatics Luma™, a revolutionary new scientific data platform that helps scientists and administrators in life sciences [...]
October 24, 2023
—Combines Three Leading Live Biomimetic Organoid Platforms Designed to Make R&D for Neurological Diseases Faster, More Efficient and More Successful— —AxoSim Gains Expert Scientific Team and Advanced R&D and Manufacturing Capabilities “Upriver” in Minnesota to Augment Its “Downriver” Facilities in New Orleans— New Orleans, La. ─ AxoSim, Inc., a leader in the development and application of live [...]
Waters Corporation Announces Business Unit Leadership Transition
October 24, 2023
Jonathan Pratt to Step Down to Pursue an External Opportunity Christos Ross Named Interim Senior Vice President of the Waters Division MILFORD, Mass. -- Waters Corporation (NYSE:WAT) today announced that Jonathan ("Jon") Pratt has decided to step down from his role as Senior Vice President of the Waters Division, to pursue an external opportunity. He will [...]
Quanterix Announces New Agreement To Advance Blood Based Alzheimer’s Disease Detection
October 24, 2023
Agreement provides Quanterix a license to extensively studied p-Tau 217 antibodies to enable global access to plasma-based testing for Alzheimer’s Disease research and diagnostics. BILLERICA, Mass. – Quanterix Corporation (NASDAQ: QTRX), a leading provider of ultra-sensitive research products and high-definition diagnostics, today announced the signing of a license agreement with Janssen Sciences Ireland UC (Janssen), [...]
October 24, 2023
CHARLOTESVILLE, Va. -- LumaCyte, a leading innovator in advanced single cell analysis technology and instrumentation, is proud to announce the launch of their newly redesigned flagship Radiance® instrument to meet growing demand for Laser Force Cytology™ (LFC) precision analytics in space-constrained biomanufacturing facilities. The half-sized compact design is new, occupying only 16 inches of bench [...]
October 24, 2023
Company appoints Jon Murray as VP Sales, Colleen McMillen as VP Marketing, and Dave Anstey as VP Pharma Business Development Ann Arbor, MI -- Genomenon®, Inc., a leading genomic intelligence company, has announced new executive appointments for its sales and marketing team as the company continues to expand its footprint across clinical diagnostics and pharmaceutical markets. These [...]
October 24, 2023
SANTA CRUZ, CA, USA -- "We are honored to have someone of Mikael's caliber join our team," said RealSeq Biosciences CEO, Sergio Barberan-Soler, Ph.D. "His expertise will be invaluable as we continue to develop innovative solutions for the growing field of RNA fragmentomics and novel biomarker strategies." Mikael Kubista, Ph.D. is a world-renowned expert in gene expression and qPCR analysis. [...]

